The fully automated IdyllaTM NRAS-BRAF-EGFR S492R Mutation Assay covers 18 mutations in NRAS exons 2-4 and 5 mutations in BRAF codon 600 as well as 2 EGFR mutations in codon 492 and shows an excellent concordance to reference methods of >99%.
For research use only. Not for use in diagnostic procedures.
Specimen requirements
One of the biggest challenges in oncology biomarker testing is the ability to obtain samples of sufficient size and quality. With the IdyllaTM System only a minimal amount of sample is needed
- 1x 5 μm FFPE tissue section → 50-600 mm²
- 1x 10 μm FFPE tissue section → 25-300 mm²
- Neoplastic cells ≥ 10% - if less, macrodissection is required
The opinions and conclusions expressed in the following publications are those of the individual authors and do not necessarily reflect the views and opinions of Biocartis and/or its employees.
